Floatz logo

Chloroquine

Chondrosarcoma

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Small moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
34/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Chondrosarcoma cohort.

Asset / SponsorPhaseRating
ag-120
Memorial Sloan Kettering Cancer Center
Phase 2B
Cediranib
National Cancer Institute (NCI)
Phase 1/2B
Azacitidine
IGM Biosciences, Inc.
Phase 1/2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Eli Lilly and Company
Phase 1/2CCC
Angiotensin-(1-7)
Wake Forest University Health Sciences
Phase 2CCC

View all 28 →

Same molecule, other indications

Chloroquine is also rated in:

glioblastomaDormant
B
Indicative ·
58 / 100
View asset →
hypertensive disorderDormant
CCC
Indicative ·
52 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →